Expression and purification of catalytically active, non-toxic endopeptidase derivatives of clostridium botulinum toxin type A

Protein Expression and Purification

Volumn 25, Issue 2, 2002, Pages 219-228

  Chaddock, John A ^a   Herbert, Michael H ^a   Ling, Roger J ^a   Alexander, Frances C G ^a   Fooks, Sarah J ^a   Revell, Dean F ^a   Quinn, Conrad P ^a   Shone, Clifford C ^a   Foster, Keith A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BOTULINUM TOXIN TYPE A; CATALYSIS; CLOSTRIDIUM BOTULINUM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASES; MICE; NEUROMUSCULAR AGENTS; NEUROTRANSMITTER AGENTS; RABBITS; RECOMBINANT PROTEINS;

CLOSTRIDIUM BOTULINUM; ESCHERICHIA COLI;

EID: 0036426323     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00002-5     Document Type: Article

References (30)

1. T. Sollner, S.W. Whiteheart, M. Brunner, H. Erdjument Bromaga, S. Geromanos, P. Tempst, J.E. Rothman, SNAP receptors implicated in vesicle targeting and fusion, Nature 362 (1993) 318-324
2. J. Blasi, E.R. Chapman, E. Link, T. Binz, S. Yamasaki, P. De Camilli, T.C. Sudhof, H. Niemann, R. Jahn, Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25, Nature 365 (1993) 160-163
3. C.C. Shone, P. Hambleton, J. Melling, Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH- terminus of the heavy subunit destroys toxin-binding activity, Eur. J. Biochem. 151 (1985) 75-82
4. L.L. Simpson, The origin, structure, pharmacological activity of botulinum toxin, Pharmacol. Rev. 33 (1981) 155-188
5. T. Nishiki, Y. Kamata, Y. Nemoto, A. Omori, T. Ito, M. Takahashi, S. Kozaki, Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes, J. Biol. Chem. 269 (1994) 10498-10503
6. S. Kozaki, Y. Kamata, S. Watarai, T. Nishiki, S. Mochida, Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins, Microb. Pathog. 25 (1998) 91-99
7. M. Oblatt-Montal, M. Yamazaki, R. Nelson, M. Montal, Formation of ion channels in lipid bilayers by a peptide with the predicted transmembrane sequence of botulinum neurotoxin A, Protein Sci. 4 (1995) 1490-1497
8. J. Aguilera, Clostridial neurotoxins proposal of a common nomenclature, FEMS Lett. 90 (1992) 99-100
9. 2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles, Eur. J. Biochem. 167 (1987) 175-180
10. L. Zhou, A. de Paiva, D. Liu, R. Aoki, J.O. Dolly, Expression and purification of the light chain of botulinum neurotoxin A: A single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with the heavy chain, Biochemistry 34 (1995) 15175-15181
11. V.V. Vaidyanathan, K-I. Yoshino, M. Jahnz, C. Dorries, S. Bade, S. Nauenburg, H. Niemann, T. Binz, Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, E: Domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage, J. Neurochem. 72 (1999) 327-337
12. D.B. Lacy, R.C. Stevens, Recombinant expression and purification of the botulinum neurotoxin type A translocation domain, Protein Expr. Purif. 11 (1997) 195-200
13. M.A. Clayton, J.M. Clayton, D.R. Brown, J.L. Middlebrook, Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli, Infect. Immun. 63 (1995) 2738-2742
14. C.C. Shone, H.S. Tranter, Growth of clostridia and preparation of their neurotoxins, Curr. Top. Microbiol. Immunol. 195 (1995) 143-160
15. B. Hallis, S. Fooks, C. Shone, P. Hambleton, Characterisation of monoclonal antibodies to Botulinum type A neurotoxin, in: B.R. DasGupta (Ed.), Botulinum and Tetanus Neurotoxins, Plenum Press, New York, 1993, pp. 433-436
16. S. Russell, Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001
17. C.K. Tse, J.O. Dolly, P. Hambleton, D. Wray, J. Melling, Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin, Eur. J. Biochem. 122 (1982) 493-500
18. B.R. Ransom, E. Neale, M. Henkart, P.N. Bullock, P.G. Nelson, Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties, J. Neurophysiol. 40 (1977) 1132-1150
19. S.C. Fitzgerald, A Dissection and Tissue Culture Manual of the Nervous System, Alan R. Liss Inc, New York, 1989
20. L.C. Williamson, J.L. Halpern, C. Montecucco, J.E. Brown, E.A. Neale, Clostridial neurotoxins and substrate proteolysis in intact neurons: Botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa, J. Biol. Chem. 271 (1996) 7694-7699
21. B. Hallis, B.A.F. James, C.C. Shone, Development of novel assays for Botulinum type A and B neurotoxins based on their endopeptidase activities, J. Clin. Microbiol. 34 (1996) 1934-1938
22. S. Notermans, J. Nagel, Assays for botulinum and tetanus toxins, in: L.L. Simpson (Ed.), Botulinum Neurotoxin and Tetanus Toxin, Academic Press, New York, 1989, pp. 319-331
23. E.A. Maisey, J.D.F. Wadsworth, B. Poulain, C.C. Shone, J. Melling, P. Gibbs, L. Tauc, J.O. Dolly, Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release, Eur. J. Biochem. 177 (1988) 683-691
24. A. de Pavia, J.O. Dolly, Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes, FEBS Lett. 277 (1990) 171-174
25. S. Kadhodayan, M.S. Knapp, J.J. Schmidt, S.E. Fabes, B. Rupp, R. Balhorn, Cloning, expression, one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A, Protein Expr. Purif. 19 (2000) 125-130
26. D.B. Lacy, W. Tepp, A.C. Cohen, B.R. DasGupta, R.C. Stevens, Crystal structure of botulinum neurotoxin type A and implications for toxicity, Nat. Struct. Biol. 5 (1998) 898-902
27. D.B. Lacy, R.C. Stevens, Sequence homology and structural analysis of the clostridial neurotoxins, J. Mol. Biol. 291 (1999) 1091-1104
28. M.P. Byrne, L.A. Smith, Development of vaccines for prevention of botulism, Biochimie 82 (2000) 955-966
29. J.A. Chaddock, J.R. Purkiss, L.M. Friis, J.D. Broadbridge, M.J. Duggan, S.J. Fooks, C.C. Shone, C.P. Quinn, K.A. Foster, Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A, Infect. Immun. 68 (2000) 2587-2593
30. J.A. Chaddock, J.R. Purkiss, M.J. Duggan, C.P. Quinn, C.C. Shone, K.A. Foster, A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitter release in vitro, Growth Factors 18 (2000) 147-155